Date: prev next · Thread: first prev next last


Ik heb het even in Wie doet wat sheet gezet

<https://www.avast.com/sig-email?utm_medium=email&utm_source=link&utm_campaign=sig-email&utm_content=webmail>
Virusvrij.
www.avast.com
<https://www.avast.com/sig-email?utm_medium=email&utm_source=link&utm_campaign=sig-email&utm_content=webmail>
<#DAB4FAD8-2DD7-40BB-A1B8-4E2AA1F9FDF2>

Op zo 31 mei 2020 om 10:57 schreef Rob Westein <rwestein@planet.nl>:

ben ik nu mee bezig.

On 31-05-2020 08:28, Kees Kriek wrote:
Hoofdstuk 8, Kennismaken met Base, van de Basishandleiding voor
LibreOffice
moet nog nagelezen worden.
Dit is het laatste hoofdstuk van deze handleiding, waarna het boek
aangemaakt kan worden.
Wie heeft er zin en tijd om dit te doen?

Groeten, Kees

<
https://www.avast.com/sig-email?utm_medium=email&utm_source=link&utm_campaign=sig-email&utm_content=webmail

Virusvrij.
www.avast.com
<
https://www.avast.com/sig-email?utm_medium=email&utm_source=link&utm_campaign=sig-email&utm_content=webmail

<#DAB4FAD8-2DD7-40BB-A1B8-4E2AA1F9FDF2>

Op za 23 mei 2020 om 12:08 schreef Rob Westein <rwestein@planet.nl>:

Dit weekend gaat dit in de herkansing...

/Rob

On 17-05-2020 11:20, Rob Westein wrote:
Zal proberen dit komende week op te pakken.

hfst 2 van de Base handleiding staat ook nog te wachten op nalezen
dacht ik....

/Rob

On 17-05-2020 08:00, Kees Kriek wrote:
Misschien dat Rob deze kan nalezen. Ik kan alleen nalezen op tekst en
op
juiste menuverwijzingen e.d.

Groeten, Kees

<

https://www.avast.com/sig-email?utm_medium=email&utm_source=link&utm_campaign=sig-email&utm_content=webmail


Virusvrij.
www.avast.com
<

https://www.avast.com/sig-email?utm_medium=email&utm_source=link&utm_campaign=sig-email&utm_content=webmail


<#DAB4FAD8-2DD7-40BB-A1B8-4E2AA1F9FDF2>

Op za 16 mei 2020 om 21:39 schreef <h.vdburg@hccnet.nl>:

Hallo allen,



Hoofdstuk 8, Kennismaken met Base, van de Handleiding voor
LibreOffice
staat
in Onderhanden op NextCloud om nagelezen te worden.



Met vriendelijke groet,

Henk van der Burg


--
To unsubscribe e-mail to:
documentatie+unsubscribe@nl.libreoffice.org
Problems?

https://www.libreoffice.org/get-help/mailing-lists/how-to-unsubscribe/
Posting guidelines + more:
https://wiki.documentfoundation.org/Netiquette
List archive: https://listarchives.libreoffice.org/nl/documentatie/
Privacy Policy: https://www.documentfoundation.org/privacy


--
To unsubscribe e-mail to: documentatie+unsubscribe@nl.libreoffice.org
Problems?
https://www.libreoffice.org/get-help/mailing-lists/how-to-unsubscribe/
Posting guidelines + more:
https://wiki.documentfoundation.org/Netiquette
List archive: https://listarchives.libreoffice.org/nl/documentatie/
Privacy Policy: https://www.documentfoundation.org/privacy


--
To unsubscribe e-mail to: documentatie+unsubscribe@nl.libreoffice.org
Problems?
https://www.libreoffice.org/get-help/mailing-lists/how-to-unsubscribe/
Posting guidelines + more: https://wiki.documentfoundation.org/Netiquette
List archive: https://listarchives.libreoffice.org/nl/documentatie/
Privacy Policy: https://www.documentfoundation.org/privacy


-- 
To unsubscribe e-mail to: documentatie+unsubscribe@nl.libreoffice.org
Problems? https://www.libreoffice.org/get-help/mailing-lists/how-to-unsubscribe/
Posting guidelines + more: https://wiki.documentfoundation.org/Netiquette
List archive: https://listarchives.libreoffice.org/nl/documentatie/
Privacy Policy: https://www.documentfoundation.org/privacy

Context


Privacy Policy | Impressum (Legal Info) | Copyright information: Unless otherwise specified, all text and images on this website are licensed under the Creative Commons Attribution-Share Alike 3.0 License. This does not include the source code of LibreOffice, which is licensed under the Mozilla Public License (MPLv2). "LibreOffice" and "The Document Foundation" are registered trademarks of their corresponding registered owners or are in actual use as trademarks in one or more countries. Their respective logos and icons are also subject to international copyright laws. Use thereof is explained in our trademark policy.